Explore
Validate
LearnNB100-1013
antibody from Novus Biologicals
Targeting: MARK4
FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-1013 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-1013, RRID:AB_2140908
- Product name
- Goat Polyclonal MARK4 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. This antibody is expected to recognize the reported long isoform 1 (NP_113605.2) only.
- Reactivity
- Human
- Host
- Goat
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- Store at -20C. Avoid freeze-thaw cycles.
Submitted references Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis.
Kato T, Satoh S, Okabe H, Kitahara O, Ono K, Kihara C, Tanaka T, Tsunoda T, Yamaoka Y, Nakamura Y, Furukawa Y
Neoplasia (New York, N.Y.) 2001 Jan-Feb;3(1):4-9
Neoplasia (New York, N.Y.) 2001 Jan-Feb;3(1):4-9
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: MARK4 Antibody [NB100-1013] - (0.5ug/ml) staining of human prostate lysate (35ug protein in RIPA buffer). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
